Using thermal imaging in the treatment of diabetes-related Charcot neuro-osteoarthropathy (CNO) can improve patient engagement along with being a valuable clinical tool, a case study has found.
The condition, which can severely impact mobility, independence and overall quality of life, can be difficult to detect by patients due to peripheral neuropathy, which can obscure the signs of inflammation.
A recent clinical case series retrospectively reviewed two patients with CNO where digital thermographic imaging was used as part of the routine monitoring alongside standard care.
The authors reported that the visual nature of the thermographic data helped to overcome communication barriers posed by sensory loss. Patients responded positively to visual feedback, leading to improved understanding of their condition, rationale for offloading devices and the importance of glycaemic control.
These insights enabled clinicians to engage in more meaningful, personalised conversations that supported shared decision-making and improved adherence to treatment.
They concluded: “Digital thermographic imaging offers more than a diagnostic advantage — it acts as a visual language that bridges clinical knowledge and patient experience.
“This case series demonstrates its value in improving patient engagement, supporting self-care and reinforcing adherence to offloading and metabolic control strategies in the management of Charcot neuro-osteoarthropathy.”
